QRL-101, an oral small molecule being developed by QurAlis, was safe and reduced nerve-cell overactivity in ALS patients in an early study.

BMB-101 demonstrated significant anti-seizure benefit in both cohorts with favorable safety and tolerability Absence: 73.1% median reduction in the number of absence seizure ≥3s, p = 0.012DEE: 63.3% ...

The new measure would prohibit the sale of nitrous oxide and kratom to anyone under 18. It also includes rules for retail ...

Some supplements can interact with cold and flu medications. Be aware of common interactions to promote safety and ensure proper use.

Following the signing of Joao Cancelo, it is unlikely Barcelona would want to sign any more players in the ongoing January ...

Rare Pediatric Disease Priority Review Voucher (PRV) granted by FDA at approval to be transferred from Sentynl Therapeutics ...

Disneyland fans are hoping a new Avatar boat ride will feature ground-breaking technology from a jaw-dropping attraction ...

Rare Pediatric Disease Priority Review Voucher (PRV) granted by FDA at approval to be transferred from Sentynl Therapeutics to Cyprium Cyprium eligible to receive tiered royalties and up to $129 milli ...

The woman killed by an ICE agent in Minneapolis last week served on the board of her son’s school, which linked to documents ...

Legislative leaders say "everything is on the table" in the half-year session that starts on Jan. 6 with the added pressure of election year politics.

Access the Akari CEO Corner here TAMPA, Fla. and LONDON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payloads for antib ...

C26 and C27 skarn Neodymium-praseodymium (NdPr) content represents approximately 15% of Total Rare Earth Oxides (TREO) ...